Cargando…
Evaluation of AZD1446 as a Therapeutic in DYT1 Dystonia
DYT1 dystonia is an early-onset, hyperkinetic movement disorder caused by a deletion in the gene TOR1A, which encodes the protein torsinA. Several lines of evidence show that in animal models of DTY1 dystonia, there is impaired basal dopamine (DA) release and enhanced acetylcholine tone. Clinically,...
Autores principales: | Zimmerman, Chelsea N., Eskow Jaunarajs, Karen L., Meringolo, Maria, Rizzo, Francesca R., Santoro, Massimo, Standaert, David G., Pisani, Antonio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5468415/ https://www.ncbi.nlm.nih.gov/pubmed/28659770 http://dx.doi.org/10.3389/fnsys.2017.00043 |
Ejemplares similares
-
Alpha‐Synuclein is Involved in DYT1 Dystonia Striatal Synaptic Dysfunction
por: Ponterio, Giulia, et al.
Publicado: (2022) -
Vesicular Acetylcholine Transporter Alters Cholinergic Tone and Synaptic Plasticity in DYT1 Dystonia
por: Tassone, Annalisa, et al.
Publicado: (2021) -
DYT1 dystonia increases risk taking in humans
por: Arkadir, David, et al.
Publicado: (2016) -
A role for cerebellum in the hereditary dystonia DYT1
por: Fremont, Rachel, et al.
Publicado: (2017) -
DYT-TOR1A dystonia: an update on pathogenesis and treatment
por: Fan, Yuhang, et al.
Publicado: (2023)